LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

作者: Li Ding-Zhou , Isabelle Margaill , Bruno Palmier , Didier Pruneau , Michel Plotkine

DOI: 10.1038/SJ.BJP.0705385

关键词: IschemiaBradykininEndocrinologyBlood–brain barrierBrain ischemiaNeuroprotectionCerebral edemaInternal medicineTraumatic brain injuryAnesthesiaMedicineB2 Bradykinin Receptor

摘要: Bradykinin promotes neuronal damage and brain edema through the activation of B2 receptor. The neuroprotective effect LF 16-0687 Ms, a receptor antagonist, has been described when given prior to induction transient focal cerebral ischemia in rat, but there are no data regarding consequence treatment after injury. Therefore, murine model middle artery occlusion (MCAO), we evaluated Ms and/or onset on neurological deficit, infarct volume inflammatory responses including edema, blood–brain barrier (BBB) disruption neutrophil accumulation. LF (1, 2 4 mg kg−1) administered 0.5 h before and, 1.25 6 MCAO, decreased by maximum 33% significantly improved recovery. When at 0.25 6.25 (1.5, 3 25% score. Post-treatment with (1.5 (−28%), BBB (−60%) accumulation (−65%) induced ischemia. Physiological parameters were not modified Ms. These emphasize role bradykinin development lesion, deficit resulting from antagonist might represent new therapeutic approach pharmacological stroke. Keywords: ischemia, mice, neuroprotection, inflammation Introduction Bradykinin is generated plasma tissue kininogen action kallikrein (Bhoola et al., 1992). All components kallikrein–kinin system have identified various species human (Kizuki 1994; Walker 1995; Raidoo 1996). actions mediated G-protein coupled (constitutive) B1 (inducible) subtypes; however accounts for majority acute physiological effects (Marceau, Regoli 1998). located endothelial cells (Wahl 1996), neurons (Raidoo & Bhoola, 1997; Chen 2000), astrocytes microglia (Hosli Hosli, 1993). In neuroglial tissues, induces production release proinflammatory mediators such as reactive oxygen (Rosenblum, 1987; Ellis, 1990; Sobey 1997), nitric oxide (Katusic 1993; Gorlach Wahl, prostanoids (Gecse 1989), excitatory amino-acid neurotransmitters (Parpura Jeftinija 1996) cytokines (Cunha triggers reactions arteriolar dilatation, loss cerebrovascular autoregulation, cell lesion increased vascular permeability (Whalley 1983; Unterberg 1984; Wahl These events lead formation, ultimately injury death (Unterberg 1986; Francel, 1992; 1995). considered an important mediator associated Baethmann, An increase levels was observed during global rat (Kamiya 1993) pathway reported patients (Wagner 2002). Although number experimental studies showed that nonpeptide (Pruneau 1999b), reduced function rodent models traumatic closed head trauma 1999a; Verrecchia 2000; Rachinsky 2001; Kaplanski 2002), controlled cortical impact (Stover 2000) cold (Schulz Plesnila 2001), only few investigated contribution Relton al. (1997) demonstrated CP-0597, peptide swelling, size behavioral outcomes body weight Using same model, Zausinger (2002) neuroprotective, further supporting detrimental ischemic damage. However, this study, date, addition, study examining mice brain. Therefore, main purpose present evaluate potential value histological following (MCAO) mice.

参考文章(72)
Hideyuki Kamii, Hiroyuki Kinouchi, Frank R. Sharp, Charles J. Epstein, Stephen M. Sagar, Pak H. Chan, Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice. Brain Research. ,vol. 662, pp. 240- 244 ,(1994) , 10.1016/0006-8993(94)90818-4
Christoph Görlach, Tibor Hortobágyi, Szabolcs Hortobágyi, Zoltán Benyó, Jane Relton, Eric Taylor Whalley, Michael Wahll, Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury. Journal of Neurotrauma. ,vol. 18, pp. 833- 838 ,(2001) , 10.1089/089771501316919193
Earl F. Ellis, Julie Chao, Marcia L. Heizer, Brain kininogen following experimental brain injury: evidence for a secondary event Journal of Neurosurgery. ,vol. 71, pp. 437- 442 ,(1989) , 10.3171/JNS.1989.71.3.0437
Kanti Bhoola, Reena Ramsaroop, Johanna Plendl, Bilkish Cassim, Zodwa Dlamini, Sarala Naicker, Kallikrein and Kinin Receptor Expression in Inflammation and Cancer Biological Chemistry. ,vol. 382, pp. 77- 89 ,(2001) , 10.1515/BC.2001.013
Simone Wagner, Pamela Kalb, Martina Lukosava, Ulrich Hilgenfeldt, Markus Schwaninger, Activation of the tissue kallikrein–kinin system in stroke Journal of the Neurological Sciences. ,vol. 202, pp. 75- 76 ,(2002) , 10.1016/S0022-510X(02)00208-3
Soraia K.P Costa, Ronilson A Moreno, Laura C.M Esquisatto, Luiz Juliano, Susan D Brain, Gilberto De Nucci, Edson Antunes, Role of kinins and sensory neurons in the rat pleural leukocyte migration induced by Phoneutria nigriventer spider venom. Neuroscience Letters. ,vol. 318, pp. 158- 162 ,(2002) , 10.1016/S0304-3940(01)02498-3
Frank C. Barone, L. M. Hillegass, W. J. Price, R. F. White, E. V. Lee, G. Z. Feuerstein, H. M. Sarau, R. K. Clark, D. E. Griswold, Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification Journal of Neuroscience Research. ,vol. 29, pp. 336- 345 ,(1991) , 10.1002/JNR.490290309
DIDIER PRUNEAU, ILIA CHORNY, VADIM BENKOVITZ, ALAN ARTRU, LEONID ROITBLAT, YORAM SHAPIRA, Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma. Journal of Neurotrauma. ,vol. 16, pp. 1057- 1065 ,(1999) , 10.1089/NEU.1999.16.1057
Christopher G. Sobey, Donald D. Heistad, Frank M. Faraci, Mechanisms of Bradykinin-Induced Cerebral Vasodilatation in Rats: Evidence That Reactive Oxygen Species Activate K+ Channels Stroke. ,vol. 28, pp. 2290- 2295 ,(1997) , 10.1161/01.STR.28.11.2290
Deshandra M Raidoo, Kanti D Bhoola, Kinin receptors on human neurones Journal of Neuroimmunology. ,vol. 77, pp. 39- 44 ,(1997) , 10.1016/S0165-5728(97)00048-9